The future of clinical trials

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
The future of clinical trials
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

The future of clinical trials

The future of clinical trials in 2023 – Full Service CRO

The future of clinical trials is an exciting and rapidly evolving landscape, with advances in technology and changes in regulatory frameworks paving the way for more efficient and effective clinical research.

In this blog post, we will explore some of the key trends and developments that are shaping the future of clinical trials.

One of the most promising trends in clinical research is the use of digital technologies to collect and analyze data.

Digital health technologies, such as wearable devices, mobile apps, and telemedicine, are increasingly being used to remotely monitor patients and collect data in real-time.

This allows researchers to collect a more comprehensive and accurate picture of patients’ health and to analyze data in real-time, potentially accelerating the pace of clinical trials.

The use of artificial intelligence (AI) and machine learning (ML) is also transforming the clinical trial landscape. AI and ML algorithms can analyze vast amounts of data to identify patterns, predict outcomes, and optimize trial design.

This can help researchers to identify the most promising candidates for clinical trials, design more efficient trials, and identify potential safety issues early on.

Another trend in clinical research is the use of decentralized clinical trials (DCTs). DCTs enable patients to participate in clinical trials from their homes, reducing the need for frequent visits to a clinical site.

This can improve patient recruitment and retention, reduce costs, and increase the speed of clinical trials. DCTs also have the potential to increase the diversity of trial participants, as they can be conducted across multiple locations and geographies.

The regulatory environment is also evolving to support innovation and streamline the clinical trial process.

For example, the U.S. Food and Drug Administration (FDA) has established a breakthrough therapy designation, which enables expedited development and review of drugs for serious or life-threatening conditions.

The future of clinical trials

The FDA has also established a program to encourage the use of real-world evidence (RWE) in drug development, which allows researchers to use data from sources such as electronic health records and claims data to support regulatory decision-making.

Another promising development is the emergence of precision medicine, which seeks to tailor treatments to individual patients based on their unique genetic, environmental, and lifestyle factors.

Precision medicine has the potential to transform clinical trials by enabling researchers to identify subgroups of patients who are most likely to benefit from a particular treatment, and to design trials that are more focused and efficient.

Despite these exciting trends, there are also challenges that need to be addressed in the future of clinical trials.

One of the biggest challenges is the lack of diversity in clinical trial participants, which can limit the generalizability of trial results.

Efforts are underway to address this issue, such as the FDA’s guidance on increasing diversity in clinical trials and the inclusion of minority and underrepresented groups in clinical research.

Another challenge is the complexity and cost of clinical trials, which can deter smaller companies and academic institutions from conducting research.

Efforts to simplify and streamline the clinical trial process, such as the use of adaptive trial designs and the standardization of trial protocols, could help to address these challenges.

In conclusion, the future of clinical trials is bright, with exciting developments in digital health technologies, AI and ML, decentralized trials, and precision medicine.

These trends have the potential to transform clinical research by improving patient outcomes, accelerating the pace of drug development, and reducing costs.

However, challenges such as the lack of diversity in clinical trial participants and the complexity of the clinical trial process need to be addressed in order to fully realize the potential of these innovations.

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

The future of clinical trials

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
The future of clinical trials

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

The future of clinical trials

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

The future of clinical trials

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

The future of clinical trials

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

The future of clinical trials

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
The future of clinical trials

The Cohortias Team

The future of clinical trials

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

The future of clinical trials

Network & Partnerships